Brendan F Gilmore Selected Research

Brendan F Gilmore Research Topics

Disease

21	Infections 01/2019 - 11/2008
5	Inflammation (Inflammations) 01/2019 - 11/2008
3	Bacterial Infections (Bacterial Infection) 01/2022 - 08/2010
3	Urinary Tract Infections (Urinary Tract Infection) 10/2021 - 08/2010
3	Neoplasms (Cancer) 12/2018 - 12/2010
2	Dysbiosis 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 11/2019 - 02/2017
2	Pseudomonas Infections 01/2015 - 01/2012
2	Persistent Infection 01/2012 - 11/2008
2	Phototoxic Dermatitis (Phototoxicity) 07/2006 - 10/2004
1	Proteus Infections 10/2021
1	Necrosis 05/2021
1	Pneumonia (Pneumonitis) 01/2019
1	Osteoporosis 01/2018
1	Colitis 01/2017
1	Rupture 04/2016
1	Cross Infection (Nosocomial Infection) 07/2015
1	Infertility (Sterility) 02/2015
1	Cystic Fibrosis (Mucoviscidosis) 01/2015
1	Hemolysis 09/2014
1	Fibrosis (Cirrhosis) 06/2014
1	Idiopathic Pulmonary Fibrosis 06/2014
1	Communicable Diseases (Infectious Diseases) 03/2013
1	Animal Diseases 05/2012
1	Melanoma (Melanoma, Malignant) 07/2011
1	Asthma (Bronchial Asthma) 03/2011
1	Clostridium Infections 03/2011
1	Keloid 12/2010
1	Cicatrix (Scar) 12/2010
1	Prostatitis 11/2008
1	Neoplasm Metastasis (Metastasis) 07/2006

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 08/2010
5	Biocompatible Materials (Biomaterials)IBA 02/2017 - 07/2012
3	Anti-Infective Agents (Microbicides)IBA 01/2022 - 12/2008
3	EnzymesIBA 10/2021 - 10/2014
3	Peptides (Polypeptides)IBA 01/2019 - 10/2014
3	Proteins (Proteins, Gene)FDA Link 04/2013 - 07/2011
3	Peptide Hydrolases (Proteases)FDA Link 06/2012 - 12/2010
2	Plasma GasesIBA 11/2019 - 12/2018
2	Pharmaceutical PreparationsIBA 01/2015 - 01/2011
2	HydrogelsIBA 10/2014 - 07/2012
2	Antimicrobial PeptidesIBA 07/2012 - 01/2011
2	3-((aminoiminomethyl)thio)-2-propenoic acid (ZAPA)IBA 10/2011 - 11/2008
2	Metalloproteases (Metalloproteinases)IBA 06/2011 - 11/2008
2	Virulence Factors (Pathogenicity Factors)IBA 06/2011 - 11/2008
2	fibroblast activation protein alphaIBA 12/2010 - 07/2006
2	AcidsIBA 07/2006 - 10/2004
1	Polysaccharides (Glycans)IBA 01/2022
1	Disinfectants (Biocides)IBA 05/2021
1	Caspase 3 (Caspase-3)IBA 05/2021
1	Chemotactic FactorsIBA 01/2019
1	CytokinesIBA 01/2019
1	VenomsIBA 01/2019
1	CathelicidinsIBA 01/2019
1	SolutionsIBA 12/2018
1	LipopolysaccharidesIBA 07/2016
1	Sulfhydryl Compounds (Thiols)IBA 04/2016
1	Cysteine Proteases (Cysteine Protease)IBA 04/2016
1	Particulate MatterIBA 04/2016
1	cathepsin SIBA 04/2016
1	Caspase 1 (ICE Protease)IBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Ionic LiquidsIBA 08/2015
1	Bulk DrugsIBA 02/2015
1	Deoxyribonucleases (DNase)FDA Link 01/2015
1	dornase alfa (Pulmozyme)FDA Link 01/2015
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2015
1	GelsIBA 09/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Brefeldin AIBA 06/2014
1	Cystatin CIBA 06/2014
1	Indicators and Reagents (Reagents)IBA 05/2012
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2012
1	AminoglycosidesIBA 01/2012
1	Immunoglobulin A (IgA)IBA 10/2011
1	Becaplermin (PDGF-BB)FDA Link 07/2011
1	Pancreatic Elastase (Elastase)IBA 06/2011
1	FluoroquinolonesIBA 03/2011
1	Immunoglobulin G (IgG)IBA 03/2011
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2010
1	Extracellular Matrix ProteinsIBA 12/2010
1	CoagulaseIBA 12/2008
1	EstersIBA 07/2006

Therapy/Procedure

6	Therapeutics 01/2020 - 12/2008
5	Catheters 10/2021 - 08/2010
2	Prostheses and Implants (Prosthesis) 02/2017 - 01/2012
1	Cardiac Catheters 02/2017
1	Length of Stay 10/2015
1	Phage Therapy 10/2011
1	Topical Administration 10/2004